J Furrer

690 total citations
22 papers, 470 citations indexed

About

J Furrer is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, J Furrer has authored 22 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 7 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in J Furrer's work include Renal and Vascular Pathologies (6 papers), Hormonal Regulation and Hypertension (5 papers) and Electrolyte and hormonal disorders (4 papers). J Furrer is often cited by papers focused on Renal and Vascular Pathologies (6 papers), Hormonal Regulation and Hypertension (5 papers) and Electrolyte and hormonal disorders (4 papers). J Furrer collaborates with scholars based in Switzerland and Germany. J Furrer's co-authors include Georg Schulthess, Edouard Battegay, Christian Breymann, Pierre‐Alexandre Krayenbuehl, A Grüntzig, N. Goebel, W Siegenthaler, U. Kuhlmann, Urs M. Lütolf and W Vetter and has published in prestigious journals such as Blood, Annals of Internal Medicine and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

J Furrer

22 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Furrer Switzerland 9 173 166 157 112 60 22 470
H P Krohn Germany 9 84 0.5× 88 0.5× 58 0.4× 68 0.6× 85 1.4× 16 420
E. von Kaulla United States 8 41 0.2× 75 0.5× 174 1.1× 44 0.4× 38 0.6× 16 352
Sandra Jamieson United Kingdom 10 173 1.0× 71 0.4× 77 0.5× 18 0.2× 38 0.6× 13 414
Robert Dluhy United States 6 35 0.2× 125 0.8× 181 1.2× 172 1.5× 56 0.9× 6 459
Francisco S. Lozano Spain 13 266 1.5× 99 0.6× 61 0.4× 27 0.2× 39 0.7× 45 493
Robert M. Gipstein United States 7 108 0.6× 91 0.5× 23 0.1× 19 0.2× 78 1.3× 8 411
Eero Ikkala Finland 11 27 0.2× 46 0.3× 206 1.3× 118 1.1× 22 0.4× 19 376
Janine Dörffler-Melly Switzerland 13 348 2.0× 125 0.8× 117 0.7× 26 0.2× 28 0.5× 19 669
Jürgen Heinrich Germany 7 109 0.6× 213 1.3× 130 0.8× 13 0.1× 81 1.4× 9 498
V. Grimaudo Switzerland 8 130 0.8× 52 0.3× 99 0.6× 22 0.2× 13 0.2× 12 342

Countries citing papers authored by J Furrer

Since Specialization
Citations

This map shows the geographic impact of J Furrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Furrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Furrer more than expected).

Fields of papers citing papers by J Furrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Furrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Furrer. The network helps show where J Furrer may publish in the future.

Co-authorship network of co-authors of J Furrer

This figure shows the co-authorship network connecting the top 25 collaborators of J Furrer. A scholar is included among the top collaborators of J Furrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Furrer. J Furrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krayenbuehl, Pierre‐Alexandre, Edouard Battegay, Christian Breymann, J Furrer, & Georg Schulthess. (2011). Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood. 118(12). 3222–3227. 183 indexed citations
2.
Furrer, J, et al.. (2001). Carcinoid Syndrome, Acromegaly, and Hypoglycemia Due to an Insulin-Secreting Neuroendocrine Tumor of the Liver. The Journal of Clinical Endocrinology & Metabolism. 86(5). 2227–2230. 29 indexed citations
3.
Uk, Franzeck, et al.. (1995). Skin Capillary Aneurysms Detected by Indocyanine Green in Type I Diabetes with and without Retinal Microaneurysms. PubMed. 15(4). 193–198. 10 indexed citations
4.
Furrer, J, et al.. (1983). [Transcapillary diffusion of Na-fluorescein in skin areas of the dorsum of the foot in juvenile diabetics].. PubMed. 113(51). 1964–9. 4 indexed citations
5.
Kuhlmann, U., W Vetter, J Furrer, et al.. (1980). Renovascular Hypertension: Treatment by Percutaneous Transluminal Dilatation. Annals of Internal Medicine. 92(1). 1–6. 54 indexed citations
6.
Furrer, J, et al.. (1980). Treatment of abdominal angina with percutaneous dilatation of an arteria mesenterica superior stenosis. CardioVascular and Interventional Radiology. 3(1). 43–44. 94 indexed citations
7.
Furrer, J, et al.. (1980). [Furosemide and metolazone: a highly effective diuretic combination].. PubMed. 110(48). 1825–9. 8 indexed citations
8.
Vetter, W., H. Vetter, W. Tenschert, et al.. (1979). Prognostischer Wert der seitengetrennten Reninbestimmung im Nierenvenenblut. 1 indexed citations
9.
Tenschert, W., W Vetter, A. Studer, et al.. (1979). [Minoxidil in treatment resistant hypertension].. PubMed. 109(47). 1869–73. 1 indexed citations
10.
Vetter, W, H. Vetter, W. Tenschert, et al.. (1979). Renovaskul�re Hypertonie. Journal of Molecular Medicine. 57(17). 863–873. 7 indexed citations
11.
Vetter, W., H. Vetter, U. Kuhlmann, et al.. (1979). [Clinical picture, diagnosis and therapy of renovascular hypertension].. PubMed. 109(11). 384–94. 3 indexed citations
12.
Rampini, Silvana K., et al.. (1978). Congenital pseudohypoaldosteronism: case report and review. Effect of indomethacin during sodium chloride depletion.. PubMed. 33(2). 153–67. 18 indexed citations
13.
Vetter, H., A. Studer, F. Witassek, et al.. (1978). PRIMARY ALDOSTERONISM: INABILITY TO DIFFERENTIATE UNILATERAL FROM BILATERAL ADRENAL LESIONS BY VARIOUS ROUTINE CLINICAL AND LABORATORY DATA AND BY PERIPHERAL PLASMA ALDOSTERONE. European Journal of Endocrinology. 89(4). 710–725. 27 indexed citations
14.
Vetter, W, K Záruba, R. Beckerhoff, et al.. (1977). Control of Plasma Aldosterone during Hemodialysis in Patients with Terminal Renal Failure. ˜The œNephron journals/Nephron journals. 18(2). 114–123. 4 indexed citations
15.
Kuhlmann, U., H. Vetter, G Pouliadis, et al.. (1977). [Studies on the differential determination of renin activity in renal venous blood in renal artery stenosis].. PubMed. 107(48). 1787–9. 1 indexed citations
16.
Vetter, W, K Záruba, R. Beckerhoff, et al.. (1976). Control of plasma aldosterone in terminal renal failure before and after nephrectomy and after renal transplantation.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 6(4). 433–6. 2 indexed citations
17.
Beckerhoff, R., J Furrer, W. Vetter, Juerg Nussberger, & W Siegenthaler. (1976). Hypotension during angiotensin blockade with saralasin.. BMJ. 2(6040). 849–849. 3 indexed citations
18.
Nussberger, J., et al.. (1976). [Blood pressure and renin activity in essential hypertension under pindolol].. PubMed. 106(24). 831–4. 1 indexed citations
19.
Vetter, W., H. Vetter, R. Beckerhoff, et al.. (1976). [Endocrine hypertension in primary aldosteronism and in Cushing's syndrome].. PubMed. 106(50). 1773–7. 3 indexed citations
20.
Beckerhoff, R., et al.. (1976). [Effect of the angiotensin antagonist saralasin (1-sar-8-ala-angiotensin II) on the blood pressure in secondary hypertension].. PubMed. 106(49). 1738–41. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026